China Foods Holdings Ltd (OTC: CFOO) is a China-based health and wellness company that sells healthcare products and consulting services, with a secondary wine import business, through its operating subsidiary Guangzhou Xiao Xiang Health Industry Company Limited (GXXHIC). Revenue comes from direct product sales and fee-based health consulting, with the healthcare segment generating $327,107 of the $327,871 total revenue in FY2025. The company is incorporated in Delaware and conducts substantially all operations in China through a holding structure that includes intermediate entities in the British Virgin Islands and Hong Kong. GXXHIC was organized under Chinese law on March 8, 2017, and CFOO completed the acquisition of the operating entity in July 2020. Total revenue was $327,871 in FY2025, up from $233,339 in FY2024, but the company reported a net loss of $398,672 in FY2025 and $455,571 in FY2024. No dividends have been paid, and operations are financed primarily through director advances and related-party financing.

Revenue model

Transactional revenue from two segments: (1) Healthcare, comprising sales of healthcare products ($258,802 in FY2025) and health consulting service fees ($68,305 in FY2025); (2) Wine, comprising sales of imported wine products ($764 in FY2025). The healthcare segment represented nearly all revenue in FY2025.

Products and services

Healthcare products spanning five categories: Nutrition Catering, Special Health Food, Health Supplements, Skincare, and Wine. Health consulting advisory services. Imported wine, including a French red wine sourced via a distribution agreement with Shenzhen Guisheng Supply Chain Co., Ltd. The company also disclosed plans to add beauty products, including facial masks, to its product range.

Customers and end markets

Retail and individual consumers in China across all age groups with health and wellness needs. Accounts receivable terms are generally 30 to 90 days from completion of service. No customer concentration data disclosed in the filing excerpts.

Value-chain role

Product distributor and service provider. Sources healthcare and wellness products for resale and imports wine directly from origin countries through supply chain agents, then packages and labels for the Chinese market. Also provides fee-based health consulting directly to customers.

Geographic exposure

Substantially all operations conducted in China. Wine sourced from France and imported through supply chain agents. Corporate holding entities domiciled in Delaware, British Virgin Islands, and Hong Kong.

Source: SEC 10-K, filed 2026-04-16

Industry: Medicinal Chemicals & Botanical Products